SMi's 8th Annual Pharmaceutical Microbiology UK Conference

SMi's 8th Annual Pharmaceutical Microbiology UK Conference is organized by SMi Group Ltd and will be held from Jan 21 - 22, 2019 at Copthorne Tara Hotel London Kensington, London, England, United Kingdom.

The target audience for this medical event is Senior Microbiologist, Lead Scientist, Lab Mgr, QA Specialist Drug Substance External Manufacturer, BD Mngr - Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist

Conference Description :
Discover how to keep up with regulatory changes and maintain the utmost efficiency during production and testing. The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is expanding. In fact, the value of the rapid microbiology testing market is expected to reach US$6.2 Bln by 2022, expanding at CAGR of 7.3% from 2016 to 2022.

Conference Highlights :
• Sanofi spotlight session on rapid micro methods and the future of endotoxin testing.
• Discuss the challenges in developing a contamination control strategy for different product types.
• Examine the strengths and weaknesses of VHP as a bio-contamination control agent in GMP applications.
• Explore mold contamination challenges and how to overcome these challenges.
• Gain insight into various real-life case studies from experiences in the cleanroom.
• Hear from experts on the current regulations, challenges and trends in mycoplasma safety testing.

Conference Topics :
• Rapid Microbial Methods.
• Revision of Annex 1 and impact on pharmaceutical microbiology.
• Contamination control strategies and case studies.
• Mycoplasma detection, prevention and control.
• Future of endotoxin testing in pharmaceutical industries.
• Strengths and weaknesses of vaporized Hydrogen peroxide as a bio-contamination control agent.
• Mold contamination control.
• Influence of temperature of incubation on results of microbiological environmental monitoring.

Conference Objectives are :
• Challenges in development of a contamination control strategy for different product types.
• A series of learning experiences within contamination from Boehringer Ingelheim.
• The use of vaporized hydrogen peroxide bio-decontamination technology in microbiology contamination control.
• Case studies in deinococcus and fungal and bacterial spores in cleanrooms.
• Influence of temperature of incubation on results of microbiological environmental monitoring.
• Risk mitigation strategies for animal-derived raw materials.

Speakers Include:
• Alexander Stoll, VP Competence Center Microbiology and Aseptic Technique Quality Management, Fresenius Kabi
• Di Morris, Senior Manager, Team Leader, Vaccines Quality Audit, GSK
• Philippe Dutot, Sterility Assurance Specialist, Novo Nordisk
• Thierry Bonnevay, Microbiology Platform Head, Analytical Research and Development, Sanofi Pasteur
• Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca

Time: 8:30 am to 6:00 pm

Additional details will be posted as soon as they are available.